CISNET Policy and Individual Decision Tools

Mammography Outcomes Policy (Mammo OUTPut) Tool — The optimal age to initiate breast cancer screening is a source of substantial debate in health care policy, which can lead to uncertainty for health care administrators and clinicians seeking to create policies for their organizations. This web-based decision aid is intended to provide health care policy-makers with quantitative data on the tradeoffs of benefits and harms related to the age of mammography screening initiation in different groups of women.

State Colorectal Cancer Decision Tool — This website provides state decision makers and health professionals with planning tools for their area’s colorectal cancer screening programs.  Decision makers and health professionals can choose their state of interest and screening budget available to them (annual budget and years of funding). The web tool will then provide estimates for the number of people who could be screened and the number of colonoscopies required as well as the resulting colorectal cancer deaths prevented and life years gained given these restraints.

Decision Tool for Women with BRCA Mutations — This decision support tool is designed for joint use by women with BRCA mutations and their health care providers, to guide management of cancer risks. This tool is not intended to replace any aspect of medical care. Testing for BRCA gene mutations, and managing hereditary cancer risk, is a complex process which should be supervised by expert medical professionals. The goal of this tool is to inform discussion between providers and patients about options for reducing cancer risk.

Colorectal Cancer Mortality Projections Website — This website helps cancer control planners, program staff and policy makers consider the impact of risk factor reduction, increased early detection, and increased access to optimal treatment on future colorectal cancer mortality rates. This work was completed in 2005 and has not been updated. Although the projections themselves are out of date, they are still instructive with respect to the relative magnitude of the impact of different cancer control interventions on mortality.